Bristol Myers Squibb SWOT Analysis, USP & Competitors

Posted in Pharmaceuticals and Healthcare, Total Reads: 6138

SWOT Analysis of Bristol Myers Squibb with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

Bristol Myers Squibb

Parent Company

Bristol Myers Squibb




Health care

Tagline/ Slogan

Together we can prevail


Bristol-Myers Squibb is a global BioPharma company focused to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.



Diseases such as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis and psychiatric disorders

Target Group

Healthcare professionals, doctors, pharmacists


Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

SWOT Analysis


1.Deliver new medicines regularly

2. Provide free medications to qualifying patients with financial problems in the U.S.

3. Employ 44000 people all over world, strong global footprint

4. Corporate strategy with the acquisition of many other companies

5. String of new technologies, alliances has strengthened the brand

6. Co-development and co-commercialization agreements with companies have boosted image


1.Strong dependence on working with third parties to improve and enhance abilities

2. Substantial drop in sales for two key drugs: Plavix, a blood thinner, and Pravachol, a cholesterol-lowering drug.

3. Company layoffs and post retirement plans may affect employee relations.


1. Security technologies to make packaging and products less vulnerable to counterfeiting and to secure their movement within the supply chain

2. An integrated team addresses counterfeiting, product tampering, theft and diversion issues

3. Expand access to its products through strategic acquisitions & partnerships.


1. The company acquires biotech companies, technology and expertise and hence a threat to its culture is infused ever more deeply.

2. Counterfeit drugs and product tampering, theft or diversion represent a threat

3. Pricing  pressures

4. Global economic slowdown




2.Roche Holding


4.Merck & Co.


6.Teva Pharmaceutical


Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.